Skip to main content
Clinical Trials/JPRN-jRCT1032230108
JPRN-jRCT1032230108
Recruiting
未知

Multimodal Imaging Studies of Neural Circuit Dynamics of the Self

Matsumoto Madoka0 sites600 target enrollmentJune 2, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Psychiatric disorders (schizophrenia, mood disorders)
Sponsor
Matsumoto Madoka
Enrollment
600
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 2, 2023
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Matsumoto Madoka

Eligibility Criteria

Inclusion Criteria

  • 1\) Normal participants without mental disorders
  • 2\) Patients with DSM\-5 (Diagnostic and Statistical Manual of Mental Disorders\-5\) diagnosis of mental illness (schizophrenia patients, mood disorder patients) who are visiting our outpatient clinic or are hospitalized.
  • 3\) Participants with characteristics of gifted (developmental disability gray zone), with at least one of the five composite scores (full test IQ (FSIQ), verbal comprehension index (VCI), perceptual reasoning index (PRI), working memory index (WMI), processing speed index (PSI)) on any of the WAIS/WISC/WPPSI tests at least one of which exceeds 130 (Lang et al., 2019 Assessment). In addition, based on background information from the interview (gender, age, history, medical history, history of treatment, primary disease, history of allergies, history of adverse reactions, etc.), the possibility of the entry of disease groups with past and current treatment history will be eliminated.
  • 4\) Participants who are between 20 and 45 years of age.
  • 5\) Participants who have the capacity to consent in person and the ability to consent in writing

Exclusion Criteria

  • 1\) Left\-handed
  • 2\) Participants with a coexisting alcohol/substance use disorder or a history of alcohol/substance use disorder within 2 years
  • 3\) Participants who are not eligible for MRI imaging due to the presence of metal in the body (e.g., brain aneurysm clips, cardiac pacemakers, etc.)
  • 4\) Patients who have difficulty entering the MRI and MEG machines due to claustrophobia.
  • 5\) Patients with evidence of cerebral organic disease
  • 6\) Patients with life\-threatening serious or unstable physical diseases
  • 7\) Pregnant women
  • 8\) Participants deemed inappropriate by the principal investigator.

Outcomes

Primary Outcomes

Not specified

Similar Trials